Rudnik v. Norwich Pharmacal Co.

34 A.D.2d 912, 311 N.Y.S.2d 363, 1970 N.Y. App. Div. LEXIS 4577
CourtAppellate Division of the Supreme Court of the State of New York
DecidedJune 9, 1970
StatusPublished
Cited by3 cases

This text of 34 A.D.2d 912 (Rudnik v. Norwich Pharmacal Co.) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rudnik v. Norwich Pharmacal Co., 34 A.D.2d 912, 311 N.Y.S.2d 363, 1970 N.Y. App. Div. LEXIS 4577 (N.Y. Ct. App. 1970).

Opinion

Judgment entered June 9, 1967 after a jury trial in favor of plaintiffs, reversed on the facts and on the law and in the exercise of discretion, and a new trial directed, with costs and disbursements to abide the event. We conclude that the defendants were deprived of a fair trial and an unprejudiced consideration of the ease by reason of the continuing exchanges between court and counsel for the defendants in the presence of the jury. Although defendants’ counsel was not free from fault in this area, some of the observations of the court may well have prejudiced the defendants. There were criticisms of the defendants’ counsel to such an extent that in our opinion the calm, dispassionate and deliberate consideration of the facts by the jury was unduly impeded. The Trial Judge should at all times maintain an impartial forbearance. The development of the facts in the presence of the jury should be uncomplicated by personalities [913]*913and acrimony. (Habenicht v. B.N.O. Theatres¡ 23 A D 2d 378; Salzano V. City of New York, 22 A D 2d 656; Levy v. Reilly, 18 A D 2d 632; Buckley v. 2570 Broadway Gorp., 12 A D 2d 473; Kamen Soap Prods. Go. v. Prusansky & Prusansky, 11 A D 2d 676.) We must note our disagreement with the concurring opinion insofar as error is charged in the refusal to instruct the jury as to the unexplained failure of the plaintiff’s physician to testify. The courts in considering the failure of a party to call a witness within his control by being in his employ or so related to him or on such terms with him as to indicate friendliness, have stated that it gives rise to a presumption or warrants an inference by the jury that the testimony would have been adverse to the party so failing to call the witness or would have been unfavorable or prejudicial to him; but this has been usually qualified by stating what is plainly the correct rule for instructing a jury, viz., that in such circumstances the jury have a right to acoept the testimony before them which might have been but was not controverted, and to take it most strongly against the party who might have controverted it but failed to do so.” (Perlman v. Shanck, 192 App. Div. 179, 183, italics in original.) The doctor who administered the drug did not fall within the defined class of witnesses. Hence the court’s refusal to charge as to his nonappearance as a witness did not constitute error. (Vollmer v. Automobile Fire Ins. Co., 207 App. Div. 67, 70; Beehil v. Fraas, 129 App. Div. 563, 566, revd. on other grounds 197 1ST. Y. 64; 2 Wigmore, Evidence [3d ed.], § 287, p. 168; Richardson, Evidence [8th ed.], § 92, p. 65; McCormick, Evidence, § 249, p. 534.) Concur — Capozzoli, J. P., Markewich and Tilzer, JJ.; McGivern, J. concurs in part and dissents in part in the following memorandum: Although I concur in the direction of a new trial, it is not alone for the sole reason assigned by the majority. The conduct of a trial should indeed be seriously viewed, but the benefit of a new trial should not for improper conduct alone be given when as in the instant case, the medical support of the plaintiffs’ ease is so weak, or nonexistent, the complaint could as justifiably be dismissed on the record before us now. Two of the plaintiffs’ doctors never categorically said that the drug Altafur was the competent producing cause of her malady. Dr. Jacobson did, but on cross-examination, even he admitted he was not familiar with the proper dosage, had never used the drug and had never seen the instructions on the package. Yet, he was the plaintiffs’ expert ” witness. And not one of the physicians called by her actually treated her at the time in suit. Taking an informed notice of the possible side effects of all antibiotics, not excluding aspirin, the effort to hold the defendant liable for an overdosage of one drug, when not less than twelve others were also given, stretches the doctrine of proximate cause to the breaking point. Particularly is this so when it is admitted that plaintiff received not only an overdosage of Altafur but before that received massive doses of “ Stilbesterol, Dermerol, Gantrisin, aspirin, furadantin, seconal, aureomycin, Chloromycetin, ilosone, paregoric, mereuhydrin, erythromycin.” In any event, a new trial, eleven years after the administration of the drug Altafur, in itself borders on a travesty. The record discloses not only the inherent weakness of the plaintiffs’ case but also many errors of an extraordinary character warranting a new trial. These errors, briefed by both parties on this appeal, necessitate a disposition and should not be ignored by an appellate court ordering a new trial. There was the arbitrary abridgment and preclusion of critical cross-examination, and the exclusion of evidence that the cause of the plaintiff wife’s visual disability was her own physical condition and the gigantic administration of antibiotics other than Altafur properly given. Then, in addition, there were two crucial errors: (a) the refusal to grant the defendant’s request to charge [914]*914that the failure of the plaintiffs to call the plaintiff wife’s own doctor, who recommended the overdose of Altafur, was a factor properly to be considered by the jury, and (b) the refusal of the court to charge the jury in respect of the effect of an overdose of Altafur in contravention of the instructions for safe usage contained in the package insert. Concerning the failure of the plaintiffs to call Dr. Shapiro, I completely dissent from the majority’s conclusion that the court’s refusal to charge as to his nonappearance as a witness did not constitute error.” In my view, Dr. Shapiro, as the plaintiff wife’s treating physician, the one responsible for and who recommended the overdosage, was the one witness most likely to shed light on her condition. He should have been produced, or his absence explained, out of the very necessity of the case. It was with him the plaintiff wife had a special relationship^ and it was both natural and reasonable to expect his testimony, a trial being a quest for the truth. In the nature of things he had a superior and a unique knowledge of a material point on which the plaintiffs had the 'burden of proof. Additionally, the record before us is open to the interpretation that the administration of the drug in question may have helped save the plaintiff wife’s life, but the overdose, if any, as prescribed by her own doctor, may have triggered the consequences to her eyes, which constituted the main gravamen of her complaint. Her own expert, Dr. Jacobson, admitted her life was in danger, and there is testimony that the administration of Altafur saved her life. Norwich, the defendant-appellant, meritoriously argues that her physician may have intentionally administered overdosages to rescue her from the brink. The art of healing frequently calls for a balancing of risks and dangers to a patient”. (Perlmutter v. Beth David Hosp., 308 N. Y. 100, 107.) If so, this might absolve her physician and affect the issue of proximate cause as to the manufacturer. Thus, the testimony of the treating physician, who prescribed the dosages, became a vital factor in her cause and in an understanding of the entire case. A charge, appropriately phrased, on the subject of his unexplained failure to testify, was in order and warranted under the proof and circumstances of the case. A request of this nature was made. It was refused by the court. In my judgment, this was error. Actually, the charge requested was the following: “VII. If you find that the plaintiff’s obstetrician, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Placencia v. Torres
194 Misc. 2d 623 (Civil Court of the City of New York, 2003)
People v. Benson
233 A.D.2d 749 (Appellate Division of the Supreme Court of New York, 1996)
Testa v. Federated Department Stores, Inc.
118 A.D.2d 696 (Appellate Division of the Supreme Court of New York, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
34 A.D.2d 912, 311 N.Y.S.2d 363, 1970 N.Y. App. Div. LEXIS 4577, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rudnik-v-norwich-pharmacal-co-nyappdiv-1970.